Explore › Outcome › Poly-substance use frequency
Outcome

Poly-substance use frequency

Also known as: Poly-substance use frequency (z-score composite of alcohol, marijuana, cigarette use days) Poly-substance use frequency and individual substance use
12 findings 1 paper 7 related entities View in graph →

Related entities

interventions
Depression symptoms1 Negative mood regulation expectancies1 Lower grade point average1
conditions
Substance Use2 poly-substance use2
populations
Adolescents4
studys
PMC81207434

Findings (50)

None
decline

More depression symptoms were associated with greater frequency of poly-substance use over time, with effects moderated by gender (significant for males but not females for poly-substance and marijuan

Effect: decline; beta = .05, t(7726) = 4.24

Size: beta = .05, t(7726) = 4.24
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More depression symptoms were associated with greater frequency of poly-substance use over time, with effects moderated by gender (significant for males but not females for poly-substance and marijuan

Effect: decline; beta = .05, t(7726) = 4.24

Size: beta = .05, t(7726) = 4.24
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More depression symptoms were associated with greater frequency of poly-substance use over time, with effects moderated by gender (significant for males but not females for poly-substance and marijuan

Effect: decline; beta = .05, t(7726) = 4.24

Size: beta = .05, t(7726) = 4.24
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More depression symptoms were associated with greater frequency of poly-substance use over time, with effects moderated by gender (significant for males but not females for poly-substance and marijuan

Effect: decline; beta = .05, t(7726) = 4.24

Size: beta = .05, t(7726) = 4.24
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More depression symptoms were associated with greater frequency of poly-substance use over time, with effects moderated by gender (significant for males but not females for poly-substance and marijuan

Effect: decline; beta = .05, t(7726) = 4.24

Size: beta = .05, t(7726) = 4.24
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More depression symptoms were associated with greater frequency of poly-substance use over time, with effects moderated by gender (significant for males but not females for poly-substance and marijuan

Effect: decline; beta = .05, t(7726) = 4.24

Size: beta = .05, t(7726) = 4.24
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More depression symptoms were associated with greater frequency of poly-substance use over time, with effects moderated by gender (significant for males but not females for poly-substance and marijuan

Effect: decline; beta = .05, t(7726) = 4.24

Size: beta = .05, t(7726) = 4.24
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More depression symptoms were associated with greater frequency of poly-substance use over time, with effects moderated by gender (significant for males but not females for poly-substance and marijuan

Effect: decline; beta = .05, t(7726) = 4.24

Size: beta = .05, t(7726) = 4.24
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More depression symptoms were associated with greater frequency of poly-substance use over time, with effects moderated by gender (significant for males but not females for poly-substance and marijuan

Effect: decline; beta = .05, t(7726) = 4.24

Size: beta = .05, t(7726) = 4.24
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More depression symptoms were associated with greater frequency of poly-substance use over time, with effects moderated by gender (significant for males but not females for poly-substance and marijuan

Effect: decline; beta = .05, t(7726) = 4.24

Size: beta = .05, t(7726) = 4.24
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More depression symptoms were associated with greater frequency of poly-substance use over time, with effects moderated by gender (significant for males but not females for poly-substance and marijuan

Effect: decline; beta = .05, t(7726) = 4.24

Size: beta = .05, t(7726) = 4.24
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More depression symptoms were associated with greater frequency of poly-substance use over time, with effects moderated by gender (significant for males but not females for poly-substance and marijuan

Effect: decline; beta = .05, t(7726) = 4.24

Size: beta = .05, t(7726) = 4.24
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More depression symptoms were associated with greater frequency of poly-substance use over time, with effects moderated by gender (significant for males but not females for poly-substance and marijuan

Effect: decline; beta = .05, t(7726) = 4.24

Size: beta = .05, t(7726) = 4.24
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More depression symptoms were associated with greater frequency of poly-substance use over time, with effects moderated by gender (significant for males but not females for poly-substance and marijuan

Effect: decline; beta = .05, t(7726) = 4.24

Size: beta = .05, t(7726) = 4.24
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More depression symptoms were associated with greater frequency of poly-substance use over time, with effects moderated by gender (significant for males but not females for poly-substance and marijuan

Effect: decline; beta = .05, t(7726) = 4.24

Size: beta = .05, t(7726) = 4.24
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More depression symptoms were associated with greater frequency of poly-substance use over time, with effects moderated by gender (significant for males but not females for poly-substance and marijuan

Effect: decline; beta = .05, t(7726) = 4.24

Size: beta = .05, t(7726) = 4.24
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More depression symptoms were associated with greater frequency of poly-substance use over time, with effects moderated by gender (significant for males but not females for poly-substance and marijuan

Effect: decline; beta = .05, t(7726) = 4.24

Size: beta = .05, t(7726) = 4.24
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More depression symptoms were associated with greater frequency of poly-substance use over time, with effects moderated by gender (significant for males but not females for poly-substance and marijuan

Effect: decline; beta = .05, t(7726) = 4.24

Size: beta = .05, t(7726) = 4.24
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More depression symptoms were associated with greater frequency of poly-substance use over time, with effects moderated by gender (significant for males but not females for poly-substance and marijuan

Effect: decline; beta = .05, t(7726) = 4.24

Size: beta = .05, t(7726) = 4.24
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More depression symptoms were associated with greater frequency of poly-substance use over time, with effects moderated by gender (significant for males but not females for poly-substance and marijuan

Effect: decline; beta = .05, t(7726) = 4.24

Size: beta = .05, t(7726) = 4.24
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More depression symptoms were associated with greater frequency of poly-substance use over time, with effects moderated by gender (significant for males but not females for poly-substance and marijuan

Effect: decline; beta = .05, t(7726) = 4.24

Size: beta = .05, t(7726) = 4.24
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More depression symptoms were associated with greater frequency of poly-substance use over time, with effects moderated by gender (significant for males but not females for poly-substance and marijuan

Effect: decline; beta = .05, t(7726) = 4.24

Size: beta = .05, t(7726) = 4.24
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More depression symptoms were associated with greater frequency of poly-substance use over time, with effects moderated by gender (significant for males but not females for poly-substance and marijuan

Effect: decline; beta = .05, t(7726) = 4.24

Size: beta = .05, t(7726) = 4.24
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More depression symptoms were associated with greater frequency of poly-substance use over time, with effects moderated by gender (significant for males but not females for poly-substance and marijuan

Effect: decline; beta = .05, t(7726) = 4.24

Size: beta = .05, t(7726) = 4.24
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More depression symptoms were associated with greater frequency of poly-substance use over time, with effects moderated by gender (significant for males but not females for poly-substance and marijuan

Effect: decline; beta = .05, t(7726) = 4.24

Size: beta = .05, t(7726) = 4.24
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More depression symptoms were associated with greater frequency of poly-substance use over time, with effects moderated by gender (significant for males but not females for poly-substance and marijuan

Effect: decline; beta = .05, t(7726) = 4.24

Size: beta = .05, t(7726) = 4.24
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More depression symptoms were associated with greater frequency of poly-substance use over time, with effects moderated by gender (significant for males but not females for poly-substance and marijuan

Effect: decline; beta = .05, t(7726) = 4.24

Size: beta = .05, t(7726) = 4.24
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

Size: beta = .04, t(7726) = 3.57
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

Size: beta = .04, t(7726) = 3.57
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

Size: beta = .04, t(7726) = 3.57
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

Size: beta = .04, t(7726) = 3.57
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

Size: beta = .04, t(7726) = 3.57
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

Size: beta = .04, t(7726) = 3.57
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

Size: beta = .04, t(7726) = 3.57
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

Size: beta = .04, t(7726) = 3.57
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

Size: beta = .04, t(7726) = 3.57
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

Size: beta = .04, t(7726) = 3.57
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

Size: beta = .04, t(7726) = 3.57
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

Size: beta = .04, t(7726) = 3.57
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

Size: beta = .04, t(7726) = 3.57
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

Size: beta = .04, t(7726) = 3.57
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

Size: beta = .04, t(7726) = 3.57
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

Size: beta = .04, t(7726) = 3.57
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

Size: beta = .04, t(7726) = 3.57
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

Size: beta = .04, t(7726) = 3.57
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

Size: beta = .04, t(7726) = 3.57
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

Size: beta = .04, t(7726) = 3.57
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

Size: beta = .04, t(7726) = 3.57
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

Size: beta = .04, t(7726) = 3.57
PMC8120743
Finding details → · Paper → · Graph →
None
decline

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

Size: beta = .04, t(7726) = 3.57
PMC8120743
Finding details → · Paper → · Graph →

Papers (1)